[1]
S. K. Ramasubbu, S. Dakshinamurthy, S. Palepu, A. Bandyopadhyay, and S. K. Rajendran, “Rimegepant: first novel oral calcitonin gene-related peptide inhibitor for migraine”, Int J Basic Clin Pharmacol, vol. 9, no. 5, pp. 829–832, Apr. 2020.